Table 1.
Subcutaneous fat | Omental fat | |
---|---|---|
(a) Protein (Xu et al. [12▪▪]) | ||
p-AMPK/AMPK | − | − |
Nampt | 0 | − |
Protein carbonylation | + | + |
(b) Gene expression | ||
Xu et al. [12▪▪] | ||
CD4 | + | + |
CD68 | 0 | + |
MPO | 0 | + |
CCL5 | 0 | + |
p-Selectin | 0 | + |
SIRT1 | 0 | 0 |
Nampt | 0 | − |
PGC1α | 0 | − |
Angiotensinogen | + | + |
AMPKα1 | − | 0 |
AMPKα2 | + | 0 |
Klöting et al. [8▪▪] | ||
SIRT1 | − | − |
IL-6 | + | + |
IL-8 | 0 | + |
Nampt | 0 | + |
Hardy et al. [10▪] | ||
CCL2, 3, 4, 8 | 0 | + |
IL-8 | 0 | + |
Goossens et al. [13▪] | ||
PGC1α | − | ND |
Gillum et al. [14▪] | ||
SIRT1 | − | ND |
In study by Xu et al. [12▪▪], seven of the eight patients in the insulin-resistant group and three of eight in the insulin-sensitive group were diabetic (not insulin treated). Patients with diabetes or a family history of diabetes were excluded by Klöting et al. [8▪▪]. + and − indicate a factor in increased or decreased. 0, no change; ND, not determined.